KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Debt to Equity (2016 - 2025)

Resmed (RMD) has disclosed Debt to Equity for 16 consecutive years, with $0.04 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 2080.46% year-over-year to $0.04, compared with a TTM value of $0.04 through Dec 2025, up 2080.46%, and an annual FY2025 reading of $0.0, down 18.5% over the prior year.
  • Debt to Equity was $0.04 for Q4 2025 at Resmed, down from $0.04 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.04 in Q3 2025 and bottomed at $0.0 in Q2 2025.
  • Average Debt to Equity over 5 years is $0.01, with a median of $0.0 recorded in 2022.
  • The sharpest move saw Debt to Equity crashed 31.02% in 2023, then skyrocketed 2128.9% in 2025.
  • Year by year, Debt to Equity stood at $0.0 in 2021, then plummeted by 30.57% to $0.0 in 2022, then fell by 16.61% to $0.0 in 2023, then decreased by 14.61% to $0.0 in 2024, then surged by 2080.46% to $0.04 in 2025.
  • Business Quant data shows Debt to Equity for RMD at $0.04 in Q4 2025, $0.04 in Q3 2025, and $0.0 in Q2 2025.